$ENDV ENDONOVO THERAPEUTICS, INC. Insider Trading Week 31/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENDONOVO THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ENDONOVO THERAPEUTICS, INC. in week 31/2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 02 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.03 | 2,000 | 68 | 22,141,389 | 22.1 M to 22.1 M (+0.01 %) |
Aug 02 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.03 | 2,000 | 62 | 22,139,389 | 22.1 M to 22.1 M (+0.01 %) |
Aug 02 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.03 | 5,000 | 160 | 22,137,389 | 22.1 M to 22.1 M (+0.02 %) |
Aug 02 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.03 | 2,000 | 64 | 22,132,389 | 22.1 M to 22.1 M (+0.01 %) |
Aug 02 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.03 | 5,000 | 155 | 22,130,389 | 22.1 M to 22.1 M (+0.02 %) |
Aug 02 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.03 | 2,000 | 62 | 22,125,389 | 22.1 M to 22.1 M (+0.01 %) |
Aug 02 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.03 | 5,000 | 155 | 22,123,389 | 22.1 M to 22.1 M (+0.02 %) |
Aug 02 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.03 | 5,000 | 155 | 22,118,389 | 22.1 M to 22.1 M (+0.02 %) |
Aug 02 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.03 | 5,000 | 155 | 22,113,389 | 22.1 M to 22.1 M (+0.02 %) |
Aug 02 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.03 | 2,000 | 62 | 22,108,389 | 22.1 M to 22.1 M (+0.01 %) |
Aug 02 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.03 | 5,000 | 155 | 22,106,389 | 22.1 M to 22.1 M (+0.02 %) |
Aug 02 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.03 | 3,000 | 93 | 22,101,389 | 22.1 M to 22.1 M (+0.01 %) |
Aug 02 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.03 | 3,000 | 93 | 22,098,389 | 22.1 M to 22.1 M (+0.01 %) |
Aug 02 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.03 | 3,000 | 93 | 22,095,389 | 22.1 M to 22.1 M (+0.01 %) |
Aug 02 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.03 | 2,000 | 62 | 22,092,389 | 22.1 M to 22.1 M (+0.01 %) |
Aug 02 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.03 | 3,500 | 121 | 22,090,389 | 22.1 M to 22.1 M (+0.02 %) |
Aug 02 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.03 | 2,000 | 69 | 22,086,889 | 22.1 M to 22.1 M (+0.01 %) |
Aug 02 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.03 | 3,000 | 104 | 22,084,889 | 22.1 M to 22.1 M (+0.01 %) |
Aug 02 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.04 | 2,000 | 70 | 22,081,889 | 22.1 M to 22.1 M (+0.01 %) |
Aug 02 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.04 | 2,000 | 72 | 22,079,889 | 22.1 M to 22.1 M (+0.01 %) |
Aug 02 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.04 | 2,000 | 74 | 22,077,889 | 22.1 M to 22.1 M (+0.01 %) |
Jul 31 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.04 | 2,000 | 80 | 22,075,889 | 22.1 M to 22.1 M (+0.01 %) |
Jul 31 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.04 | 2,000 | 80 | 22,073,889 | 22.1 M to 22.1 M (+0.01 %) |
Jul 31 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.04 | 5,000 | 200 | 22,071,889 | 22.1 M to 22.1 M (+0.02 %) |
Jul 31 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.04 | 3,000 | 120 | 22,066,889 | 22.1 M to 22.1 M (+0.01 %) |
Jul 31 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.04 | 2,000 | 84 | 22,063,889 | 22.1 M to 22.1 M (+0.01 %) |
Jul 31 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.04 | 3,000 | 111 | 22,061,889 | 22.1 M to 22.1 M (+0.01 %) |
Jul 31 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.04 | 5,000 | 185 | 22,058,889 | 22.1 M to 22.1 M (+0.02 %) |
Jul 31 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.04 | 1,500 | 55 | 22,053,889 | 22.1 M to 22.1 M (+0.01 %) |
Jul 31 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.04 | 2,000 | 74 | 22,052,389 | 22.1 M to 22.1 M (+0.01 %) |
Jul 31 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.04 | 3,000 | 111 | 22,050,389 | 22 M to 22.1 M (+0.01 %) |
Jul 31 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.04 | 2,000 | 80 | 22,047,389 | 22 M to 22 M (+0.01 %) |
Jul 31 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.04 | 1,000 | 40 | 22,045,389 | 22 M to 22 M (0.00 %) |
Jul 31 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.04 | 4,000 | 160 | 22,044,389 | 22 M to 22 M (+0.02 %) |
Jul 31 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.04 | 3,000 | 120 | 22,040,389 | 22 M to 22 M (+0.01 %) |
Jul 31 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.04 | 3,000 | 120 | 22,037,389 | 22 M to 22 M (+0.01 %) |
Jul 31 2017 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.04 | 3,000 | 127 | 22,034,389 | 22 M to 22 M (+0.01 %) |